HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inger Damon Selected Research

Smallpox (Variola)

9/2023Monkeypox virus-infected individuals mount comparable humoral immune responses as Smallpox-vaccinated individuals.
1/2020Use of live Variola virus to determine whether CAST/EiJ mice are a suitable surrogate animal model for human smallpox.
11/2011Safety and immunogenicity of LC16m8, an attenuated smallpox vaccine in vaccinia-naive adults.
6/2009Proteomic screening of variola virus reveals a unique NF-kappaB inhibitor that is highly conserved among pathogenic orthopoxviruses.
9/2008Real-time PCR assay to identify variants of Vaccinia virus: implications for the diagnosis of bovine vaccinia in Brazil.
9/2007Characterization of chimpanzee/human monoclonal antibodies to vaccinia virus A33 glycoprotein and its variola virus homolog in vitro and in a vaccinia virus mouse protection model.
4/2007Adjuvant-enhanced antibody responses to recombinant proteins correlates with protection of mice and monkeys to orthopoxvirus challenges.
2/2006Chimpanzee/human mAbs to vaccinia virus B5 protein neutralize vaccinia and smallpox viruses and protect mice against vaccinia virus.
2/2006Surveillance guidelines for smallpox vaccine (vaccinia) adverse reactions.
12/2005Adverse events associated with smallpox vaccination in the United States, January-October 2003.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Inger Damon Research Topics

Disease

12Smallpox (Variola)
09/2023 - 04/2004
10Vaccinia
12/2013 - 09/2005
5Mpox (monkeypox)
11/2023 - 11/2005
4Infections
09/2023 - 05/2008
3Poxviridae Infections
01/2022 - 03/2005
2Rabies (Hydrophobia)
02/2018 - 07/2013
2Atopic Dermatitis (Atopic Eczema)
12/2013 - 05/2008
2Encephalitis (Encephalitis, Rasmussen)
07/2013 - 02/2009
1Disease Progression
12/2023
1Zoonoses
12/2023
1Exanthema (Rash)
12/2023
1Prion Diseases (Transmissible Spongiform Encephalopathies)
11/2020
1Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease)
11/2020
1Neurodegenerative Diseases (Neurodegenerative Disease)
11/2020
1Stomatitis
11/2014
1Cardiotoxicity
11/2011
1Acute Disseminated Encephalomyelitis (Postinfectious Encephalomyelitis)
02/2009
1Kaposi Varicelliform Eruption (Eczema Herpeticum)
05/2008
1Eczema
05/2008

Drug/Important Bio-Agent (IBA)

8VaccinesIBA
09/2023 - 09/2005
7Immunoglobulins (Immunoglobulin)IBA
12/2013 - 12/2005
5Smallpox Vaccine (Vaccine, Smallpox)FDA Link
09/2023 - 12/2005
4Proteins (Proteins, Gene)FDA Link
11/2020 - 06/2009
33- (2- methoxyphenyl)- 5- methoxy- 1,3,4- oxadiazol- 2(3H)- oneIBA
12/2023 - 09/2023
3AntibodiesIBA
09/2023 - 11/2005
3Immunoglobulin M (IgM)IBA
02/2018 - 03/2005
3DNA (Deoxyribonucleic Acid)IBA
11/2014 - 04/2004
2smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordicIBA
09/2023 - 01/2022
2Intravenous Immunoglobulins (IVIG)FDA Link
02/2018 - 02/2009
2Neutralizing AntibodiesIBA
02/2018 - 11/2011
1Messenger RNA (mRNA)IBA
09/2023
1AntigensIBA
09/2023
1Cytosine DeaminaseIBA
11/2022
1ACAM2000IBA
01/2022
1Prion ProteinsIBA
11/2020
1Immunoglobulin G (IgG)IBA
02/2018
1Antiviral Agents (Antivirals)IBA
01/2017
1Viral ProteinsIBA
04/2015
1ImmunosorbentsIBA
11/2011
1EnzymesIBA
11/2011
1InterferonsIBA
11/2011
1Adrenal Cortex Hormones (Corticosteroids)IBA
02/2009
1SteroidsIBA
02/2009
1Hemagglutinins (Hemagglutinin)IBA
09/2008
1SYBR Green IIBA
09/2008
1Cidofovir (Vistide)FDA Link
05/2008
1tecovirimatIBA
05/2008
1Recombinant ProteinsIBA
04/2007
1vaccinia virus B5 proteinIBA
02/2006

Therapy/Procedure

2Therapeutics
01/2020 - 01/2017
2Immunotherapy
09/2007 - 02/2006
1Transplantation
07/2013
1Organ Transplantation
07/2013